ArticleJournal of hepatocellular carcinoma2026
A Transformer-Based Deep Learning Model for predicting Early Recurrence in Hepatocellular Carcinoma After Hepatectomy Using Intravoxel Incoherent Motion Images.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to develop and validate a transformer framework-based deep learning (DL) network using intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to predict early recurrence in hepatocellular carcinoma (HCC). Materials and Methods: This retrospective study included 122 patients with HCC who underwent magnetic resonance imaging examination, including an IVIM-DWI sequence with nine b-values, before resection. These were divided into training (n=85) and test (n=37) sets. A vision transformer (ViT) framework-based DL was developed to predict early recurrence in HCC. Deep features were extracted from nine b-value DWI images and IVIM parametric maps and fused to construct the fused DL (ViT-fDL) prediction model. A clinical model was constructed using multivariate logistic regression analysis. A combined model was constructed using deep features from the ViT-fDL model and clinical independent features. The performances of the models were evaluated by discrimination, calibration, and clinical applicability. Results: Among 122 patients (108 males,14 females; mean age, 51.0 ± 11.9 years), 49 (40.1%) experienced early recurrence. The respective areas under the curve for the training and test sets were 0.755 (95% Confidence interval (CI), 0.650-0.842) and 0.764 (95% CI, 0.596-0.887) using the clinical model, 0.968 (95% CI, 0.905-0.994) and 0.815 (95% CI, 0.653-0.923) using the ViT-fDL model, and 0.991 (95% CI, 0.940-1.000) and 0.821 (95% CI, 0.660-0.927) using the combined model. Conclusion: The ViT-fDL model based on IVIM can be useful for preoperative prediction early recurrence in HCC. The combined model was a more effective and precise prediction tool than other models, promising to guide individualized postoperative monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.